INTELLIGENT BIO SOLUTIONS INC. - 8-K Filing
Intelligent Bio Solutions Inc. initiated a multi-site Method Comparison Study to support its FDA 510(k) submission for U.S. market clearance of its Intelligent Fingerprinting Drug Screening System for the opiate codeine. The study, involving 135 participants and nine operators across multiple clinical sites, aims to validate accuracy and real-world performance by July 2026. (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $INBS